英文别名 |
LMI070;Branaplam;LMI-070;NVS-SM1;Branaplam free base;5-(1H-pyrazol-4-yl)-2-(6-((2,2,6,6-tetramethylpiperidin-4-yl)oxy)pyridazin-3-yl)phenol;P12R69543A;(6Z)-3-(1H-pyrazol-4-yl)-6-[3-(2,2,6,6-tetramethylpiperidin-4-yl)oxy-1H-pyridazin-6-ylidene]cyclohexa-2,4-dien-1-one;Branaplam [INN];Branaplam (LMI070);LMI070 (NVS-SM1);BCP19909;BDBM50465914;s6642;DB14918;Q27285;1562338-42-4;Branaplam (USAN/INN);BRD-K08532119-001-01-5;LMI070;NVS-SM1;LMI070 (NVS-SM1)?;DTXSID801337133;MFCD29472288;CS-5319;Q27285985;DB-123586;C92117;SCHEMBL15475826;WHO 10380;AKOS030526592;EN300-7537428;BB178548;STWTUEAWRAIWJG-UHFFFAOYSA-N;Phenol, 5-(1H-pyrazol-4-yl)-2-(6-((2,2,6,6-tetramethyl-4-piperidinyl)oxy)-3-pyridazinyl)-;D12272;NVP-LMI070-NX;5-(1H-pyrazol-4-yl)-2-[6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazin-3-yl]phenol;CHEMBL4290141;EX-A5962;Branaplam [USAN];SCHEMBL22995506;5-(1H-pyrazol-4-yl)-2-{6-[(2,2,6,6-tetramethylpiperidin-4-yl)oxy]pyridazin-3-yl}phenol;Branaplam [USAN:INN];MS-26601;UNII-P12R69543A;HY-19620;BRANAPLAM [WHO-DD] |